Who is sponsoring NCT03819634?

NCT03819634 is sponsored by Stanford University.

What drugs are being tested in NCT03819634?

Interventions in NCT03819634: Inset II with Lantern Technology.

What condition does NCT03819634 study?

NCT03819634 studies Insulin Dependent Diabetes Mellitus 1.

Is NCT03819634 still recruiting?

NCT03819634 is currently completed. Last updated 25 May 2021.

Are results published for NCT03819634?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-05-25 · How we verify

NCT03819634: Lantern

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Longevity of Multi-Slitted Catheter With Lantern Technology

Completed NA Results posted Last updated 25 May 2021

What this trial tests

NA trial testing Inset II with Lantern Technology in Insulin Dependent Diabetes Mellitus 1 in 24 participants. Completed in 20 April 2019.

Timeline

25 January 2019

Primary endpoint
20 April 2019

20 April 2019

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	25 January 2019
Primary completion	20 April 2019
Estimated completion	20 April 2019
Sites	1 location across United States

Drugs / interventions tested

Inset II with Lantern Technology

Conditions studied

Insulin Dependent Diabetes Mellitus 1 — all drugs for Insulin Dependent Diabetes Mellitus 1 →

Sponsor

Stanford University

Who can join

22 and older, any sex, with Insulin Dependent Diabetes Mellitus 1. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Time to Infusion Set Failure Primary · 10 days of infusion set wear

Time to when the infusion set fails and needs to be replaced.

Group	Value	95% CI
Lantern Infusion Set	8.0	± 2.4

Adverse events — posted to ClinicalTrials.gov

Time frame: 10 days. Reporting threshold: 4%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Lantern Infusion Set

Serious: 0/24 (0%)

Deaths: 0/24

Other adverse events (4 terms — click to expand)

Reaction	System	Lantern Infusion Set
hyperglycemia	Endocrine disorders	—
adhesive failure	Skin and subcutaneous tissue disorders	—
subcutaneous infection	Skin and subcutaneous tissue disorders	—
ketotosis	Endocrine disorders	—

Data from ClinicalTrials.gov NCT03819634 adverse events section.

Sponsor's own description

To determine time to set failure when the Convatec Inset II with Lantern technology (Convatec Lantern) infusion set with multi-slitted catheter is worn for up to 10 days

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Longevity of the novel ConvaTec infusion set with Lantern technology.
Lal RA, Hsu L, Zhang J, Schøndorff PK, et al · · 2021 · cited 21× · PMID 33822472 · DOI 10.1111/dom.14395
Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review.
Zhang G, Romo-Anselmo E, Kwa T, Cohen O, et al · · 2023 · cited 4× · PMID 36562593 · DOI 10.1177/19322968221145731
Insulin Delivery Hardware: Pumps and Pens.
Lal RA, Leelarathna L. · · 2021 · PMID 34061635 · DOI 10.1089/dia.2021.2503

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03819634 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 25 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing